It has been a rocky week for the medical news website WebMD, and it appears that the remainder of 2012 may be equally tumultuous. On Tuesday, WebMD CEO Wayne T. Gattinella resigned, and the company announced it was not looking for a buyer after all. It informed shareholders that 2012 revenue could clock in at 2 percent to 8 percent below 2011’s revenue. One explanation for the expected lackluster growth — at best — is that advertising spending in the pharmaceutical sector is scaling back for various reasons, including the increasing use of generic medications.
Loading ...
WebMD Looking a Little Green Around the Gills
Posted by: Erika Morphy January 12, 2012 09:18 AMIt has been a rocky week for the medical news website WebMD, and it appears that the remainder of 2012 may be equally tumultuous. On Tuesday, WebMD CEO Wayne T. Gattinella resigned, and the company announced it was not looking for a buyer after all. It informed shareholders that 2012 revenue could clock in at 2 percent to 8 percent below 2011’s revenue. One explanation for the expected lackluster growth — at best — is that advertising spending in the pharmaceutical sector is scaling back for various reasons, including the increasing use of generic medications.